Heparin‐induced thrombocytopenia with thrombosis in COVID‐19 adult respiratory distress syndrome

Early reports of coronavirus disease 2019 (COVID‐19) clinical features describe a hypercoagulable state, and recent guidelines recommend prophylactic anticoagulation for patients with COVID‐19 with low‐molecular‐weight heparin, but this would be contraindicated in the presence of heparin‐induced thr...

Descripción completa

Detalles Bibliográficos
Autores principales: Riker, Richard R., May, Teresa L., Fraser, Gilles L., Gagnon, David J., Bandara, Mahesh, Zemrak, Wesley R., Seder, David B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276726/
https://www.ncbi.nlm.nih.gov/pubmed/32685905
http://dx.doi.org/10.1002/rth2.12390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276726/
https://www.ncbi.nlm.nih.gov/pubmed/32685905
http://dx.doi.org/10.1002/rth2.12390

Ejemplares similares